Cargando…
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152970/ https://www.ncbi.nlm.nih.gov/pubmed/35263983 http://dx.doi.org/10.3324/haematol.2020.265868 |
| _version_ | 1784717753124388864 |
|---|---|
| author | Nishimura, Jun-ichi Ando, Kiyoshi Masuko, Masayoshi Noji, Hideyoshi Ito, Yoshikazu Mayer, Jiri Griskevicius, Laimonas Bucher, Christoph Müllershausen, Florian Gergely, Peter Rozenberg, Izabela Schubart, Anna Chawla, Raghav Rondeau, Jean-Michel Roguska, Michael Splawski, Igor Keating, Mark T. Johnson, Leslie Danekula, Rambabu Bagger, Morten Watanabe, Yoko Haraldsson, Börje Kanakura, Yuzuru |
| author_facet | Nishimura, Jun-ichi Ando, Kiyoshi Masuko, Masayoshi Noji, Hideyoshi Ito, Yoshikazu Mayer, Jiri Griskevicius, Laimonas Bucher, Christoph Müllershausen, Florian Gergely, Peter Rozenberg, Izabela Schubart, Anna Chawla, Raghav Rondeau, Jean-Michel Roguska, Michael Splawski, Igor Keating, Mark T. Johnson, Leslie Danekula, Rambabu Bagger, Morten Watanabe, Yoko Haraldsson, Börje Kanakura, Yuzuru |
| author_sort | Nishimura, Jun-ichi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9152970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91529702022-06-13 Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria Nishimura, Jun-ichi Ando, Kiyoshi Masuko, Masayoshi Noji, Hideyoshi Ito, Yoshikazu Mayer, Jiri Griskevicius, Laimonas Bucher, Christoph Müllershausen, Florian Gergely, Peter Rozenberg, Izabela Schubart, Anna Chawla, Raghav Rondeau, Jean-Michel Roguska, Michael Splawski, Igor Keating, Mark T. Johnson, Leslie Danekula, Rambabu Bagger, Morten Watanabe, Yoko Haraldsson, Börje Kanakura, Yuzuru Haematologica Letter to the Editor Fondazione Ferrata Storti 2021-03-10 /pmc/articles/PMC9152970/ /pubmed/35263983 http://dx.doi.org/10.3324/haematol.2020.265868 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Nishimura, Jun-ichi Ando, Kiyoshi Masuko, Masayoshi Noji, Hideyoshi Ito, Yoshikazu Mayer, Jiri Griskevicius, Laimonas Bucher, Christoph Müllershausen, Florian Gergely, Peter Rozenberg, Izabela Schubart, Anna Chawla, Raghav Rondeau, Jean-Michel Roguska, Michael Splawski, Igor Keating, Mark T. Johnson, Leslie Danekula, Rambabu Bagger, Morten Watanabe, Yoko Haraldsson, Börje Kanakura, Yuzuru Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title | Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title_full | Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title_fullStr | Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title_full_unstemmed | Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title_short | Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria |
| title_sort | tesidolumab (lfg316) for treatment of c5-variant patients with paroxysmal nocturnal hemoglobinuria |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152970/ https://www.ncbi.nlm.nih.gov/pubmed/35263983 http://dx.doi.org/10.3324/haematol.2020.265868 |
| work_keys_str_mv | AT nishimurajunichi tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT andokiyoshi tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT masukomasayoshi tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT nojihideyoshi tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT itoyoshikazu tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT mayerjiri tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT griskeviciuslaimonas tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT bucherchristoph tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT mullershausenflorian tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT gergelypeter tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT rozenbergizabela tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT schubartanna tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT chawlaraghav tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT rondeaujeanmichel tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT roguskamichael tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT splawskiigor tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT keatingmarkt tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT johnsonleslie tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT danekularambabu tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT baggermorten tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT watanabeyoko tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT haraldssonborje tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria AT kanakurayuzuru tesidolumablfg316fortreatmentofc5variantpatientswithparoxysmalnocturnalhemoglobinuria |